T-cell acute lymphoblastic leukemia: The loss of PRC2 gives synthetic lethality and a therapeutic option (notice n° 174703)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01502cam a2200169 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112040001.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Andrieu, Guillaume P. |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | T-cell acute lymphoblastic leukemia: The loss of PRC2 gives synthetic lethality and a therapeutic option |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2022.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 36 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | T-cell acute lymphoblastic leukemia is a highly heterogeneous and aggressive entity within hematological malignancies, characterized by a poor prognosis, especially for refractory or relapsed cases. The multiple and complex oncogenic processes make it difficult to identify effective targeted therapies for all patients. The most immature forms of the disease frequently contain alterations in epigenetic regulators that enable the identification of patients with a poor prognosis and who are as such eligible for treatment with hypomethylating agents. Furthermore, our recent work reveals that loss of function of the Polycomb complex PRC2 is accompanied by a profound remodeling of the epigenetic landscape of blasts and gives synthetic lethality to targeting bromodomain proteins. In the era of personalized medicine, understanding epigenetic deregulations in leukemias enables the development of new effective targeted therapies for patients. |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Asnafi, Vahid |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Hématologie | 28 | 5 | 2022-09-01 | p. 209-215 | 1264-7527 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-hematologie-2022-5-page-209?lang=en">https://shs.cairn.info/journal-hematologie-2022-5-page-209?lang=en</a> |
Pas d'exemplaire disponible.
Réseaux sociaux